Comparison the efficacy of Tadalafil versus Placebo in pulmonary arterial hypertension and right ventricular dysfunction in patients with beta-thalassemia major and intermedia -

Trial Profile

Comparison the efficacy of Tadalafil versus Placebo in pulmonary arterial hypertension and right ventricular dysfunction in patients with beta-thalassemia major and intermedia -

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Beta-thalassaemia; Pulmonary arterial hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Mar 2014 Status changed from active, no longer recruiting to completed as reported by Iranian Registry of Clinical Trials record.
    • 19 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top